Healthcare Technology Report September 1, 2025
SetPoint Medical, a commercial-stage medical technology company focused on therapies for chronic autoimmune diseases, has raised $140 million in private financing to support the commercialization of its FDA-approved SetPoint System for rheumatoid arthritis (RA). The financing includes $25 million from the second tranche of its Series C round and $115 million from a Series D round co-led by Elevage Medical Technologies and Ally Bridge Group. New...
Today's Sponsors
Today's Sponsor
Topics: Medical Devices